197 related articles for article (PubMed ID: 31086208)
1. Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease.
Fronza MG; Baldinotti R; Martins MC; Goldani B; Dalberto BT; Kremer FS; Begnini K; Pinto LDS; Lenardão EJ; Seixas FK; Collares T; Alves D; Savegnago L
Sci Rep; 2019 May; 9(1):7276. PubMed ID: 31086208
[TBL] [Abstract][Full Text] [Related]
2. 1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Aβ Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.
Fronza MG; Sacramento M; Alves D; Praticò D; Savegnago L
Neurochem Res; 2022 Apr; 47(4):1110-1122. PubMed ID: 35165799
[TBL] [Abstract][Full Text] [Related]
3. Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer's Disease.
Fronza MG; Baldinotti R; Sacramento M; Gutierres J; Carvalho FB; Fernandes MDC; Sousa FSS; Seixas FK; Collares T; Alves D; Pratico D; Savegnago L
ACS Chem Neurosci; 2021 Jan; 12(1):109-122. PubMed ID: 33315382
[TBL] [Abstract][Full Text] [Related]
4. QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice.
Fronza MG; Sacramento M; Alves D; Praticò D; Savegnago L
Mol Neurobiol; 2023 Mar; 60(3):1733-1745. PubMed ID: 36567360
[TBL] [Abstract][Full Text] [Related]
5. QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis.
Fronza MG; Baldinotti R; Fetter J; Sacramento M; Sousa FSS; Seixas FK; Collares T; Alves D; Praticò D; Savegnago L
ACS Chem Neurosci; 2020 May; 11(9):1259-1269. PubMed ID: 32227985
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-κB signaling, and microglial activation.
Fronza MG; Baldinotti R; Fetter J; Rosa SG; Sacramento M; Nogueira CW; Alves D; Praticò D; Savegnago L
Brain Behav Immun; 2022 Jan; 99():177-191. PubMed ID: 34624485
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Molecular Docking, and Preliminary Evaluation of 2-(1,2,3-Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease.
Costa GP; Baldinotti RSM; Fronza MG; Nascimento JER; Dias ÍFC; Sonego MS; Seixas FK; Collares T; Perin G; Jacob RG; Savegnago L; Alves D
ChemMedChem; 2020 Apr; 15(7):610-622. PubMed ID: 32012463
[TBL] [Abstract][Full Text] [Related]
9. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type.
Pacheco SM; Soares MSP; Gutierres JM; Gerzson MFB; Carvalho FB; Azambuja JH; Schetinger MRC; Stefanello FM; Spanevello RM
J Nutr Biochem; 2018 Jun; 56():193-204. PubMed ID: 29587242
[TBL] [Abstract][Full Text] [Related]
10. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer's disease via activation of Nrf2/ARE pathway and inhibition of β-secretase.
Nakhate KT; Bharne AP; Verma VS; Aru DN; Kokare DM
Biomed Pharmacother; 2018 May; 101():379-390. PubMed ID: 29501041
[TBL] [Abstract][Full Text] [Related]
12. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
[TBL] [Abstract][Full Text] [Related]
13. Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model.
Xiang X; Wang X; Wu Y; Hu J; Li Y; Jin S; Wu X
Pharmacol Biochem Behav; 2022 Mar; 214():173340. PubMed ID: 35090841
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.
Sorial ME; El Sayed NSED
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):581-593. PubMed ID: 28188358
[TBL] [Abstract][Full Text] [Related]
15. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
16. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
[TBL] [Abstract][Full Text] [Related]
17. Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
Thomé GR; Oliveira VA; Chitolina Schetinger MR; Saraiva RA; Souza D; Dorneles Rodrigues OE; Teixeira Rocha JB; Ineu RP; Pereira ME
Chem Biol Interact; 2018 Oct; 294():135-143. PubMed ID: 30120923
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models.
Liu P; Wang C; Chen W; Kang Y; Liu W; Qiu Z; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Phytomedicine; 2023 Jan; 109():154594. PubMed ID: 36610115
[TBL] [Abstract][Full Text] [Related]
19. Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions.
Teixeira FC; Gutierres JM; Soares MSP; da Siveira de Mattos B; Spohr L; do Couto CAT; Bona NP; Assmann CE; Morsch VM; da Cruz IBM; Stefanello FM; Spanevello RM
Psychopharmacology (Berl); 2020 Mar; 237(3):811-823. PubMed ID: 31834453
[TBL] [Abstract][Full Text] [Related]
20. Arbutin reduces cognitive deficit and oxidative stress in animal model of Alzheimer's disease.
Dastan Z; Pouramir M; Ghasemi-Kasman M; Ghasemzadeh Z; Dadgar M; Gol M; Ashrafpour M; Pourghasem M; Moghadamnia AA; Khafri S
Int J Neurosci; 2019 Nov; 129(11):1145-1153. PubMed ID: 31251091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
